While the facility has had several run-ins in recent years with U.S. regulators, selling the site is part of Lilly’s broader global manufacturing strategy.
Protect product integrity with ultra-pure compressed air that meets strict pharmaceutical standards. Reduce waste, slash energy costs, and drive safer, cleaner production processes — without compromise.
